The process included site investigation, planning, programming, and engineering studies including biowaste study, design charettes, etc. The project includes new biomedical research and vivarium facilities; housing spaces for BSL4, BLS3, BSL2Research; BSL4, BLS3, BSL2 Repository; BSL4, BLS3, BSL2 Transgenics; Emergents BSL4, BSL4 and BSL3 Aerobiology; Pathogenesis' Vaccine Research; Diagnostics; Host Responses; Special BSL4 In-patient Triage Suite; Therapeutics; Advanced Imaging; Bioinformatics; Genomics; Proteomics; Biopharmaceutical Development; Animal BSL4, BLS3, BSL2 Animal Research; Animal Holding for various species including non-human primates; and administrative and support space. Support facilities include medical gas utilities, conventional utilities, effluent steam sterilization, fire protection, and information systems.
The project will also include decommissioning, decontamination and demolition of the existing facilities. Construction phase services in addition to shop drawing review and approval, technical assistance, and commissioning, include full-time on-site personnel to provide daily interaction with the construction team. The new facilities will replace the outdated and crowded existing USAMRIID facilities and provide a new 930,000 gross square foot facility including state-of-the-art biocontainment laboratory space, animal facilities, and administrative offices, as well as operational and administrative support facilities.
USAMRIID’s mission of research on drugs, vaccines and diagnostics to safeguard the health of the nation’s armed forces is a critical resource for the Army, the Department of Defense, and the United States.